ASX News Health Care Immutep doses first human patient with IMP761 – a possible broad-ranging autoimmune treatment Immutep (ASX:IMM) has confirmed it's dosed the first human patient with its LAG-3 based autoimmune drug… Jonathon Davidson1 min14 August 2024 09:22 (AEDT)